blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4619418

EP4619418 - THE FGF-2 POLYPEPTIDES WITH IMPROVED STABILITY, THE PROCESS FOR PREPARING THE FGF-2 POLYPEPTIDES AND USE THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  13.02.2026
Database last updated on 10.03.2026
FormerRequest for examination was made
Status updated on  22.08.2025
FormerThe international publication has been made
Status updated on  01.06.2024
Formerunknown
Status updated on  11.12.2023
Most recent event   Tooltip13.02.2026Issuance of search results under Rule 164(2) EPC together with a communication from the examining divisionpublished on 18.03.2026 [2026/12]
13.02.2026Change - classificationpublished on 18.03.2026 [2026/12]
13.02.2026First examination report 
Applicant(s)For all designated states
BTL Healthcare Technologies a.s.
Stepánská 535/6
Nové Mesto
120 00 Praha 2 / CZ
[2025/39]
Inventor(s)01 / ROZBECKY, Daniel
25169 Kunice / CZ
02 / BOUSOVA, Kristyna Vydra
25701 Postupice / CZ
03 / VONDRASEK, Jiri
25206 Mechenice / CZ
 [2025/39]
Representative(s)DTS Patent- und Rechtsanwälte PartmbB
Brienner Straße 1
80333 München / DE
[2025/39]
Application number, filing date23817218.324.11.2023
[2025/39]
WO2023IB61877
Priority number, dateUS202263384999P25.11.2022         Original published format: US 202263384999 P
[2025/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2024110932
Date:30.05.2024
Language:EN
[2024/22]
Type: A1 Application with search report 
No.:EP4619418
Date:24.09.2025
Language:EN
The application published by WIPO in one of the EPO official languages on 30.05.2024 takes the place of the publication of the European patent application.
[2025/39]
Search report(s)International search report - published on:EP30.05.2024
(Supplementary) European search report - dispatched on:EP16.02.2026
ClassificationIPC:C07K14/50
[2025/39]
CPC:
C07K14/503 (EP,KR)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   ME,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2025/39]
TitleGerman:FGF-2-POLYPEPTIDE MIT VERBESSERTER STABILITÄT, VERFAHREN ZUR HERSTELLUNG DER FGF-2-POLYPEPTIDE UND VERWENDUNG DAVON[2025/39]
English:THE FGF-2 POLYPEPTIDES WITH IMPROVED STABILITY, THE PROCESS FOR PREPARING THE FGF-2 POLYPEPTIDES AND USE THEREOF[2025/39]
French:POLYPEPTIDES FGF-2 À STABILITÉ AMÉLIORÉE, PROCÉDÉ DE PRÉPARATION DES POLYPEPTIDES FGF-2 ET LEUR UTILISATION[2025/39]
Entry into regional phase17.06.2025National basic fee paid 
17.06.2025Designation fee(s) paid 
17.06.2025Examination fee paid 
Examination procedure17.06.2025Amendment by applicant (claims and/or description)
17.06.2025Examination requested  [2025/39]
17.06.2025Date on which the examining division has become responsible
16.02.2026Despatch of a communication from the examining division to which search results under Rule 164(2) EPC are annexed (Time limit: M04) [2026/12]
16.02.2026Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
21.10.2025Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI] WO2017089016  (UNIV MASARYKOVA et al.) [X] 1,25,26 * pg 3, l 22-25; pg 4, l 23-27; pg 6, l 3-16; cl 1-15 *[Y] 16,17,23,24 [I] 2-4
 [A] WO2013090919  (WISCONSIN ALUMNI RES FOUND et al.) [A] 1-4,16,17,20-26 * cl 1-15 *
 [X] US2020188267  (SHIN HANG-CHEOL et al.) [X] 20-22 * par 0174-0181 *
 [Y] WO2013006544  (MEDIMMUNE LLC et al.) [Y] 16,17 * par 0104, 0164 *
 [Y] US2022025334  (ELFENBEIN ARYE et al.) [Y] 23,24 * par 0361-0362 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.